worldwide offices | contact | site map | large text versionregular text version

Novartis Pharmaceuticals Corporation - A site intended for US audiences

 

 

 

Products

back to products index
 

 

Ritalin SR®
(methylphenidate hydrochloride sustained-release tablets, USP)

Product Description

Integral part of total treatment program for a stabilizing effect in ADHD/ADD.

 

For more information and product details, visit the Ritalin SR® brand website:

www.ADHDinfo.com 

Prescribing information

Prescribing information contains useful information like a treatment's ingredients and the results of the clinical trials. Here, the prescribing information will show in a separate window in an easy to print format called PDF.

Download Ritalin SR® prescribing information 

For HealthCare Professionals:

Detailed Brand information

www.ADHDinfo.com for HCPs 

HCP Resources

Research & Development 
Clinical Trials 

 

 

back to products index

PATIENT ASSISTANCE PROGRAMS

Patient Assistance Programs

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.

RESEARCH & DEVELOPMENT

Research & Development

We maintain the most promising pipeline in the industry to treat and help people around the world.

CLINICAL TRIALS

Clinical Trials

We are constantly conducting clinical trials to determine the safety and efficacy of new drugs and treatments. The success of these trials relies on patients who volunteer to participate.

NOVARTIS PHARMACEUTICALS NEWS

Read about the latest news and events from Novartis Pharmaceuticals Corporation.